Standards & Regulation

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.

Neal Baer, editor of a collection of essays on CRISPR, says we must not overlook the dark side of the technology.

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.

US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Indian CDMO denies manufacturing drug, contract testing lab pulled up for deficiencies, and lessons learned from Sanofi’s warning letter.

In part 2 of our roundtable discussion, thought leaders discuss what Trump could do for drug pricing and whether change is to be feared or embraced.

Biden pushed drug pricing reforms, whereas Trump is known for deregulation. What does this mean for pharma?

The career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

A regulatory science push in the UK includes centres for digital transformation, AI and more.